期刊文献+

还原型谷胱甘肽对维持性血液透析患者微炎症状态的影响

在线阅读 下载PDF
导出
摘要 业已证实,心、脑血管并发症是维持性血液透析(HD)患者最常见的死亡原因,而透析患者体内微炎症状态可通过不同途径造成的进展性动脉粥样硬化性心血管病是目前公认的心、脑血管并发症重要致病机制和危险因素。近年来笔者对维持性HD患者运用还原型谷胱甘肽以改善其微炎症状态,取得了较为满意的疗效,现将结果报道如下。
出处 《浙江医学》 CAS 2008年第11期1242-1243,共2页 Zhejiang Medical Journal
  • 相关文献

参考文献11

  • 1陈江华,韩飞.慢性肾脏病一体化治疗的现状与展望[J].浙江医学,2006,28(10):791-792. 被引量:10
  • 2Bistrian B, Mccowen K C, Chan S. Protein-energy malnutrition in Dialysis patients[J]. Am Kidney Dis, 1999, 33:172-175.
  • 3Hou F F, Owen W F. Beta 2-microglobulin amyloidosis: role of monocytes/macrophages mineral metabolism[J]. Curr Opin Nephrol Hypertens, 2002, 11:417-421.
  • 4Marion M, Delbose S, Dupuy A M, et al. Overproduction of reactive oxygen species in end-stage renal disease patients:a potential component of hemodialysis associated inflammation[J] Hemodial Int. 2005.9:3716.
  • 5Hemandez M R, Galan A M, Cases A, et al. Biocompatibility of cellulosic and synthetic membranes assessed by leukocyte activation[J]. Am J Nephrol, 2004, 24:235-241.
  • 6Bergstrom J, Lindolm B, Lscson E, et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients[J]? Semin Dial, 2000, 13:163-175.
  • 7Lonnemann G. Should ultra-pure dialysate be mandatory [J]? Nephrol Dial Tranaplant, 2000, 15:55-59.
  • 8Saifulla A, WatkinsB A, Saha C, et al. Oial fish oil supplementation raises blood omega-3 levels and lowers creacitive protein in haemodialysis patients a pilot study[J]. Nephrol Dial Transplant, 2007, 22:3561-3567.
  • 9MandelL J, Schnellmann R G, Jacobs W R. Intracellular glutathione in the protection from anoxic injury in renal proximal tubules[J]. J Clin Invest, 1990, 85:316-324.
  • 10Yeun J Y, Levine R A, Mantadilok N, et al. Creactive protein predicts all cause and cardiovascular mortality in hemodialysis patients[J]. Am J Kidney Dis, 2000, 35:469-476.

二级参考文献12

  • 1陈江华,何强,谢文卿,蒋华,袁静,韩飞,何永春,郑斌.高危尿毒症患者每日短时透析的临床初步经验[J].中华肾脏病杂志,2005,21(5):286-289. 被引量:14
  • 2Lysaght M J. Maintenance dialysis population dynamics: current trends and long-term implications[J]. J Am Soc Nephrol,2002,12 suppl 1 :S37-40.
  • 3Javaid B, Quigg R J. Trealment of glomerulonephrilis: will we ever have options other than steroids and cytotoxics [J]?Kidney Inl, 2005,67(5):1692-703.
  • 4Guan Y, Breyer M D. Peroxisome proliferator-activated receptors(PPARs): novel therapeutic targets in renal disease[J]. Kidney Int,2001,60(1):14-30.
  • 5Weiner D E, Sarnak M J. Managing dyslipidemia in chronic kidney disease[J]. J Gen Intern Med,2004,19(10):1045-52.
  • 6Pierratos A. New approaches to hemodialysis[J]. Annu Rev Med,2004,55:179-89.
  • 7Davies SJ, Brown EA, Frandsen NE, et al. Longitudinal membrane function in functionally anuric patients treated with APD:dala from EAPOS on the effects of glucose and ieodextrin prescription[J].Kidney Int, 2005,67(4):1609-1615.
  • 8Paniagua R, Amato D, Vonesh E,et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis:ADEMEX, a prospective, randomized, controlled trial[J]. J Am Soc Nephrol, 2002,13(5):1307-1320.
  • 9Wu J Y, Chen J H, Wang Y M, el al.hnproved clinical oulcomesin Chinese renal allograft recipienls receiving lower dose mmunosuppressants[J]. Transplantation,2004,78(5): 713-718.
  • 10陈江华,吴建永,何强,王逸民,寿张飞,黄洪锋,张晓辉,蒋华,方廉廉.供体骨髓输注诱导肾移植免疫低反应临床研究[J].中华外科杂志,2002,40(4):283-283. 被引量:9

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部